Caption Health Announces Steve Cashman as New President and CEO yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Apr 5, 2021 3:30pm Inscripta’s latest funding round will support the development and distribution of its Onyx benchtop platform, which uses CRISPR gene editing technology for fully automated genomic engineering. (AstraZeneca)
Inscripta just got another step closer to achieving its mission of bringing CRISPR gene editing technology to the scientific masses.
The genomic engineering company, a member of Fierce Medtech’s 2019 Fierce 15, recently closed a series E funding round totaling $150 million. The investment was led by Fidelity Management and Research Company and funds and accounts managed by T. Rowe Price Associates.
Upon the close of a $125 million series D round in December 2019, Inscripta calculated its total amount of funds raised since its 2015 founding at $259.5 million. With the latest influx of funds and an extension of the series D in November 2020, that total now clocks in at well over $450 million.
Press release content from Business Wire. The AP news staff was not involved in its creation.
Babson Diagnostics Named Fierce MedTech “Fierce 15” Company
March 9, 2021 GMT
AUSTIN, Texas (BUSINESS WIRE) Mar 9, 2021
Babson Diagnostics (Babson), a transformative medical technology company improving customer access to diagnostic blood testing, was named one of Fierce Medtech’s elite “Fierce 15.” The honor recognizes Babson as one of the most promising private companies in the global healthcare industry. In the year of COVID-19, Fierce Medtech, a leading daily digital news publication, examined how med tech companies are addressing the most pressing public health challenges.
ADVERTISEMENT
The conventional diagnostic blood testing experience has not changed notably since it was created 70 years ago. Babson Diagnostics is the first company to present a true alternative to venipuncture, with novel technology designed to use small fingertip samples less than one-tenth the vol
Fierce Medtech names Hyperfine as one of its Fierce 15 companies of 2020 yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
Fierce Medtech names Caption Health as one of its Fierce 15 companies of 2020
Caption Health recognized for its innovative AI-guided, FDA-cleared cardiac ultrasound software
News provided by
Share this article
Share this article
BRISBANE, Calif., March 8, 2021 /PRNewswire/ Caption Health today announced that it has been named by Fierce Medtech as one of 2020 s Fierce 15, designating it as one of the most promising private companies in the industry.
(PRNewsfoto/Caption Health)
Caption Health s flagship product Caption AI is the first and only AI-guided medical imaging acquisition software to obtain FDA clearance, expanding access to quality diagnostic imaging for patients and providers alike. Caption AI includes Caption Guidance™ and Caption Interpretation™, which provide real-time guidance, automated quality assessment and intelligent interpretation capabilities to enable medical professionals even those without prior ultrasound experience to perform diagnostic-qualit